Dirk W. Kirsten
Director of Finance/CFO at MEDARTIS HOLDING AG
Net worth: 146 601 $ as of 31/03/2024
Profile
Dirk W.
Kirsten is currently the Chief Financial Officer at Medartis Holding AG since 2021.
Previously, he worked as the Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004, as the Group Treasurer at Syngenta AG from 2004 to 2008, and as the Chief Financial Officer at Nobel Biocare Holding AG from 2008 to 2013.
He holds a doctorate degree from Universität zu Köln.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDARTIS HOLDING AG
0.01% | 31/12/2022 | 1,477 ( 0.01% ) | 146 601 $ | 31/03/2024 |
Dirk W. Kirsten active positions
| Companies | Position | Start |
|---|---|---|
| MEDARTIS HOLDING AG | Director of Finance/CFO | 01/03/2021 |
Former positions of Dirk W. Kirsten
| Companies | Position | End |
|---|---|---|
| NOBEL BIOCARE HOLDING AG | Director of Finance/CFO | 01/01/2013 |
| SYNGENTA | Treasurer | 01/01/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2004 |
Training of Dirk W. Kirsten
| Universität zu Köln | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| MEDARTIS HOLDING AG | Health Technology |
| Private companies | 2 |
|---|---|
Syngenta AG
 Syngenta AG Chemicals: AgriculturalProcess Industries Syngenta AG specializes in crop protection and seeds production. Its products include selective and non-selective herbicides, fungicides, insecticides, as well as field crop and vegetable seeds. The company was founded on November 12, 1999 and is headquartered in Basel, Switzerland. | Process Industries |
Nobel Biocare Holding AG
 Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Nobel Biocare Holding AG is a provider in the field of innovative implant-based dental restorations - from single-tooth to fully edentulous indications. It offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems as well as diagnostics, treatment planning, guided surgery solutions and biomaterials. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems, a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. Nobel Biocare Holding was founded in 1981 and is headquartered in Kloten, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Dirk W. Kirsten
